Apolipoprotein E Phenotype Alone Does Not Influence Survival in Alzheimer’s Disease: A Population-Based Longitudinal Study
Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer’s disease (AD). Contradictory results exist concerning the role of ApoE4 in the rate of decline and mortality in AD. Conflicting findings have also been reported about ApoE and gender interactions with respect to...
Saved in:
Published in | Neuroepidemiology Vol. 19; no. 6; pp. 327 - 332 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
01.11.2000
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer’s disease (AD). Contradictory results exist concerning the role of ApoE4 in the rate of decline and mortality in AD. Conflicting findings have also been reported about ApoE and gender interactions with respect to survival. We examined the survival of subjects with AD and non-AD controls with respect to ApoE phenotype and gender in a population-based longitudinal study. Cognitive evaluation was performed for a total of 980 subjects (then aged 69–78 years), and 48 cases with AD were identified. ApoE4 phenotype was more frequently present among subjects with AD. In the whole study population, survival was not related to the presence of AD or ApoE4 phenotype. Risk of death was increased for men compared to women, independently of the ApoE4 phenotype (HR 0.5, 95% confidence interval 0.44–0.69). In subjects with AD, the presence of ApoE4 alone did not influence survival. However, in the AD group, ApoE4-negative men had significantly increased risk of mortality compared to the risk in ApoE4-negative women (p < 0.01). We conclude that the presence of ApoE4 phenotype or AD did not influence mortality in the aged population. Once AD had become manifest, ApoE4 alone did not relate to survival. However, in subjects with AD not carrying ApoE4, men had reduced survival compared to women. |
---|---|
AbstractList | Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer's disease (AD). Contradictory results exist concerning the role of ApoE4 in the rate of decline and mortality in AD. Conflicting findings have also been reported about ApoE and gender interactions with respect to survival. We examined the survival of subjects with AD and non-AD controls with respect to ApoE phenotype and gender in a population-based longitudinal study. Cognitive evaluation was performed for a total of 980 subjects (then aged 69-78 years), and 48 cases with AD were identified. ApoE4 phenotype was more frequently present among subjects with AD. In the whole study population, survival was not related to the presence of AD or ApoE4 phenotype. Risk of death was increased for men compared to women, independently of the ApoE4 phenotype (HR 0.5, 95% confidence interval 0.44-0.69). In subjects with AD, the presence of ApoE4 alone did not influence survival. However, in the AD group, ApoE4-negative men had significantly increased risk of mortality compared to the risk in ApoE4-negative women (p < 0.01). We conclude that the presence of ApoE4 phenotype or AD did not influence mortality in the aged population. Once AD had become manifest, ApoE4 alone did not relate to survival. However, in subjects with AD not carrying ApoE4, men had reduced survival compared to women. Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer's disease (AD). Contradictory results exist concerning the role of ApoE4 in the rate of decline and mortality in AD. Conflicting findings have also been reported about ApoE and gender interactions with respect to survival. We examined the survival of subjects with AD and non-AD controls with respect to ApoE phenotype and gender in a population-based longitudinal study. Cognitive evaluation was performed for a total of 980 subjects (then aged 69-78 years), and 48 cases with AD were identified. ApoE4 phenotype was more frequently present among subjects with AD. In the whole study population, survival was not related to the presence of AD or ApoE4 phenotype. Risk of death was increased for men compared to women, independently of the ApoE4 phenotype (HR 0.5, 95% confidence interval 0.44-0.69). In subjects with AD, the presence of ApoE4 alone did not influence survival. However, in the AD group, ApoE4-negative men had significantly increased risk of mortality compared to the risk in ApoE4-negative women (p < 0.01). We conclude that the presence of ApoE4 phenotype or AD did not influence mortality in the aged population. Once AD had become manifest, ApoE4 alone did not relate to survival. However, in subjects with AD not carrying ApoE4, men had reduced survival compared to women. |
Author | Kuusisto, Johanna Lempiäinen, Päivi Koivisto, Anne M. Koivisto, Keijo Kervinen, Kari Helkala, Eeva-Liisa Kesäniemi, Y. Antero Laakso, Markku Mykkänen, Leena Soininen, Hilkka |
Author_xml | – sequence: 1 givenname: Anne M. surname: Koivisto fullname: Koivisto, Anne M. – sequence: 2 givenname: Päivi surname: Lempiäinen fullname: Lempiäinen, Päivi – sequence: 3 givenname: Keijo surname: Koivisto fullname: Koivisto, Keijo – sequence: 4 givenname: Eeva-Liisa surname: Helkala fullname: Helkala, Eeva-Liisa – sequence: 5 givenname: Leena surname: Mykkänen fullname: Mykkänen, Leena – sequence: 6 givenname: Johanna surname: Kuusisto fullname: Kuusisto, Johanna – sequence: 7 givenname: Kari surname: Kervinen fullname: Kervinen, Kari – sequence: 8 givenname: Y. Antero surname: Kesäniemi fullname: Kesäniemi, Y. Antero – sequence: 9 givenname: Markku surname: Laakso fullname: Laakso, Markku – sequence: 10 givenname: Hilkka surname: Soininen fullname: Soininen, Hilkka |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11060507$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFu1DAQhi1URLeFA2ckZHFA4hAY23HicAvdpa20KpUK58hNJq2L1w52UmlRD30NXo8nqemuWgkhMRfPWN_8v0b_Htlx3iEhLxm8Z0xWHyAVL3jJn5AZy7nIgIPaITPgkmVSSNglezFeASRYVc_ILmNQgIRyRm7qwVsz-CH4EY2jC3p6ic6P6wFpbZMNnXuM9MSP9Nj1dkLXIj2bwrW51pamhdr-vESzwvD79lekcxNRR_xIa3rqh8nq0XiXfUpfHV16d2HGqTMubZ6lZv2cPO21jfhi--6Tb58XXw-OsuWXw-ODepm1QhVj1uZ9X_WtgIKJHAAl5sCQCQEgpOhyrnutsJdMQKU4qvwcqrZQrGCyy9Mo9snbjW668seEcWxWJrZorXbop9iUXFQc8uq_ICtVqZgSCXzzF3jlp5AOiw0XvCpKUDxB7zZQG3yMAftmCGalw7ph0PwJrnkILrGvt4LT-Qq7R3Kb1KPjdx0uMDwAJ4v5vUIzdH2CXv0T2njcAQlEqJ4 |
CitedBy_id | crossref_primary_10_1089_rej_2011_1169 crossref_primary_10_1016_j_neurobiolaging_2007_12_003 crossref_primary_10_1093_gerona_gls192 crossref_primary_10_1212_01_WNL_0000118210_12660_C2 crossref_primary_10_1212_01_wnl_0000334278_11022_42 crossref_primary_10_1007_s11357_010_9144_x crossref_primary_10_1002_gps_2039 crossref_primary_10_1093_gerona_glad168 crossref_primary_10_1002_gps_371 crossref_primary_10_1212_01_wnl_0000277320_50685_7c crossref_primary_10_1016_j_neulet_2005_08_002 crossref_primary_10_1212_WNL_59_7_1034 crossref_primary_10_1016_j_jalz_2011_12_004 crossref_primary_10_1007_s10654_007_9202_6 crossref_primary_10_1159_000068779 crossref_primary_10_1212_WNL_58_7_1045 crossref_primary_10_1212_01_wnl_0000188871_74093_12 |
Cites_doi | 10.1001/jama.272.21.1666 |
ContentType | Journal Article |
Copyright | 2000 S. Karger AG, Basel Copyright 2000 S. Karger AG, Basel Copyright S. Karger AG Nov/Dec 2000 |
Copyright_xml | – notice: 2000 S. Karger AG, Basel – notice: Copyright 2000 S. Karger AG, Basel – notice: Copyright S. Karger AG Nov/Dec 2000 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7U7 7U9 7X7 7XB 88E 88G 88I 8AF 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. M0S M1P M2M M2P PQEST PQQKQ PQUKI PRINS PSYQQ Q9U S0X 7X8 |
DOI | 10.1159/000026272 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Proquest Health and Medical Complete ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database (Proquest) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Journals (ProQuest) ProQuest Science Journals ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Psychology Neurosciences Abstracts MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1423-0208 |
EndPage | 332 |
ExternalDocumentID | 63579558 10_1159_000026272 11060507 26272 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Finland |
GeographicLocations_xml | – name: Finland |
GroupedDBID | --- 0R~ 0~5 0~B 123 29N 30W 325 36B 3O. 3V. 4.4 53G 5RE 7X7 88E 88I 8AF 8AO 8C1 8FI 8FJ 8UI AAYIC ABIVO ABJNI ABPAZ ABUWG ACGFS ACGOD ACPRK ACPSR ADAGL ADBBV ADGES AENEX AEYAO AFJJK AFKRA AFRAH AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC AZQEC BENPR BPHCQ BVXVI CAG CCPQU COF CS3 CYUIP DU5 DWQXO E0A EBS EJD EMOBN F5P FB. FYUFA GNUQQ HCIFZ HMCUK HZ~ IAO IHR IHW IY7 KUZGX M1P M2M M2P N9A O1H O9- P2P PQQKQ PROAC PSQYO PSYQQ RIG RKO RXVBD S0X UJ6 UKHRP YHZ ZGI CGR CUY CVF ECM EIF ITC NPM AAYXX CITATION 7TK 7U7 7U9 7XB 8FK C1K H94 K9. PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c386t-c4ff9fc30613400e5e401e13300353d42afa8ef5130982e84b09c681615d4e843 |
IEDL.DBID | 8C1 |
ISSN | 0251-5350 |
IngestDate | Fri Aug 16 23:23:00 EDT 2024 Fri Aug 16 09:34:31 EDT 2024 Thu Oct 10 22:13:17 EDT 2024 Thu Sep 26 16:27:28 EDT 2024 Sat Sep 28 07:36:56 EDT 2024 Thu Aug 29 12:04:22 EDT 2024 Thu Sep 05 17:58:07 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Gender Apolipoprotein E Survival Alzheimer's disease Mortality |
Language | English |
License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Copyright 2000 S. Karger AG, Basel |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c386t-c4ff9fc30613400e5e401e13300353d42afa8ef5130982e84b09c681615d4e843 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 11060507 |
PQID | 232967082 |
PQPubID | 32897 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_72392049 proquest_miscellaneous_17878183 crossref_primary_10_1159_000026272 proquest_journals_232967082 karger_primary_26272 pubmed_primary_11060507 |
PublicationCentury | 2000 |
PublicationDate | 2000-11-01 |
PublicationDateYYYYMMDD | 2000-11-01 |
PublicationDate_xml | – month: 11 year: 2000 text: 2000-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel |
PublicationTitle | Neuroepidemiology |
PublicationTitleAlternate | Neuroepidemiology |
PublicationYear | 2000 |
Publisher | S. Karger AG |
Publisher_xml | – name: S. Karger AG |
References | Mykkänen L, Laakso M, Uusitupa M, Pyörälä K: Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990;11:1099-1105. Drachman DA, O'Donnel BF, Lew RA, Swearer JM: The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course. Arch Neurol 1990;47:851-856.2375690 Wolf PA, Cobb JL, D'Agostino RB: Epidemiology of Stroke; in Barnet HJM, Mohr JP, Stein BM, Yatsy FM (eds): Stroke. Pathophysiology, diagnosis, and management, ed 2. New York, Churchill Livingstone, 1992, pp 3-27. Cox DR: Regression models and life-tables. J R Stat Soc 1972;34:187-201. Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ: The impact of apolipoprotein E4 on cause of death in Alzheimer's disease. Neurology 1997;49:76-81.9222173 Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM, for the APOE and Alzheimer's Disease Meta Analysis Consortium: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA 1997;278:1349-1356.9343467 Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Coneally PM, Schmader KE, Tanzi RE, Gusella JF, Small GW, Roses AD, Pericak-Vance MA, Haines JL: Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995;45:1323-1328.7617191 Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, Pyörälä K, Kesäniemi YA, Riekkinen P, Laakso M: Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. BMJ 1994;309:636-638.8086986 Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castaneda C, Bylsma F, Tycko B, Mayeux R: The absence of an apolipoprotein 4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 1997;41:615-620.9153523 Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB: Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 1998;51:149-153.9674794 Slooter AJ, Houwing-Duistermaat JJ, van Harskamp F, Cruts M, Van Broeckhoven C, Breteler MMB, Hofman A, Stijnen T, van Duijn CM: Apolipoprotein E genotype and progression of Alzheimer's disease. The Rotterdam Study. J Neurol 1999;246:304-308.10367700 Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT: Apolipoprotein E genotype does not influence rates of cognitive decline. Neurology 1996;47:444-448.8757018 Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ: Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994;272:1666-1671.796689410.1001/jama.272.21.1666 Tilvis RS, Strandberg TE, Juva K: Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998;46:712-715.9625186 ref1 |
References_xml | – ident: ref1 doi: 10.1001/jama.272.21.1666 |
SSID | ssj0015989 |
Score | 1.7158312 |
Snippet | Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer’s disease (AD). Contradictory results exist concerning the role of... Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer's disease (AD). Contradictory results exist concerning the role of... |
SourceID | proquest crossref pubmed karger |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 327 |
SubjectTerms | Aged Alzheimer Disease - genetics Alzheimer Disease - mortality Apolipoproteins E - genetics Catchment Area (Health) Cognition Disorders - diagnosis Cohort Studies Female Finland - epidemiology Follow-Up Studies Humans Male Neuropsychological Tests Original Paper Population Surveillance Survival Rate |
Title | Apolipoprotein E Phenotype Alone Does Not Influence Survival in Alzheimer’s Disease: A Population-Based Longitudinal Study |
URI | https://karger.com/doi/10.1159/000026272 https://www.ncbi.nlm.nih.gov/pubmed/11060507 https://www.proquest.com/docview/232967082 https://search.proquest.com/docview/17878183 https://search.proquest.com/docview/72392049 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS9xAEB_qB0UQabXqqb0uUujT0kt2N5v4IqeeSMFDpMK9hXxs2kNN4uXuxb_emc1epAV9zGxIlp2P3-zO7AzA94FOgiDNPa4NapNMvYyHJlA8NZ4wflTI3LZOuB4HV3fy10RNXG5O49IqlzbRGuq8yuiM_CcifxRoBKzT-olT0ygKrroOGiuw5iHMUUZfeN5leCBQ2w545EVzJdTAFRZCuq3Z6Ae-9v-Bo_V7yr6eve1sWtC5_ARbzltkw5a9n-GDKbfh47WLh2_DZnvqxtrLRDvwPKSmC3Vlqy9MSzZilMJV0TkrSx6q0rC8Mg1DCpsuu5OwZoHmAgUOSWz48PzXTB_N7EfDXOzmhA1Z3bX54gR7OcNv_ZlSCiJNz5ao_QJ3l6Pf51fcdVfgmQiDOc9kUURFJgjQUZGNMrjVQg4JCi4KZFFSJKEpFIJcFPomlOkgyoKQPMRc4qPYhdUSJ74PTBQqVxT_09JIKRNkf0hCkAqlEylkD46XixzXbRGN2G4-VBR3nOjBTrv83SuOfPgfeTy6sCNxnRc4umRV7JSviTtR6cG3bhS1hkIhSWmqRRN7aKfQVRFvv6F99Bxx-9SDvVYCXmeOu-gButEH7_77EDbsrX17bfEIVuezhfmK_ss87cOKnui-ldU-rJ2Nxje3L3aB708 |
link.rule.ids | 315,783,787,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,74073,74342,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BQWMSQtCNrQyYhZD2ZK2N7XzsZapGqwJtn1qpb1E-nK2iJFnTvvSv353jZhrSeMw5Sizfne_Od74fwPeuF7lunPa4p1GbZNxLuK9dxWPdE9oJMpka6ITJ1B3N5a-FWtjanMqWVe73RLNRp0VCZ-SXaPkD10ODdV3ecwKNouSqRdB4Ca-oDRcBGHiLJt5CQ20Q8MiL5kqorm0shHTTs9FxHc95Yo5e_6Hq6_XzzqYxOsP38M56i6xfs_cDvNB5Gw4mNh_ehrf1qRurLxMdwa5PoAtlYbovLHM2YFTCVdA5K4tWRa5ZWuiKIYUt9-gkrNridoEChyTWX-3u9PKvXl9UzOZurliflQ3MFyezlzL81u2SShBpeqZF7THMh4PZzYhbdAWeCN_d8ERmWZAlggw6KrJWGkMt5JCg5KJAFkVZ5OtMoZELfEf7Mu4GieuTh5hKfBQfoZXjxE-BiUylivJ_ntRSygjZ75MQxEJ5kRSyA9_2ixyWdRON0AQfKggbTnTgqF7-5hVLPvuHPB38MCNhmWY4umdVaJWvChtR6cB5M4paQ6mQKNfFtgp7uE-hqyKef8Nz0HPE8KkDJ7UEPM4co-guutGf_vvvc3gzmk3G4fjn9PcZHJob_OYK42dobdZb_QV9mU381UjsA_os7-0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB_0KkUQ0dbq2WoXEXxamst-JOmLXNs76kePIhb6FvKx2x7WJF7uXvrXd2azF7FQHzMbkmXnc3dm5wfwMYgyrfNyxCOD2iTzUcFjoxXPzUiYMLGydNAJZzN9eiG_XqpL31Ko9WWVa5voDHVZF3RGfoCeP9EROqwD66sizk-mn5s_nACkKNHq0TQew0YktQgGsHE0mZ3_6FMKKnF4eBRTcyVU4NsMId11cAx1GIX_OKcnv6gWe_Fw6Olc0PQFPPexIxt3zH4Jj0y1BZtnPju-Bc-6MzjWXS3ahtsxQTA0tevFMK_YhFFBV02nriy7qSvDytq0DClsvsYqYe0KjQeKH5LY-Ob22sx_m8WnlvlMziEbs6YH_eLkBEuG37qaU0EiTc81rH0FF9PJz-NT7rEWeCFiveSFtDaxhSD3jmptlMGNF_JLUKpRIMMym8XGKnR5SRyaWOZBUuiY4sVS4qPYgUGFE38DTFhVKsoGRtJIKTMUhphEIhcqyqSQQ_iwXuS06VpqpG4ropK058QQtrvl71_x5N175NnkxI2kTWlxdM2q1Ktim_aCM4T9fhR1iBIjWWXqVZuO0Gph4CIefiMKMY7EzdQQXncS8HfmuKcOMKh--99_78Mmimv6_cvs2y48ddf53X3GPRgsFyvzDgObZf7ei-wdcir1ig |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Apolipoprotein+E+Phenotype+Alone+Does+Not+Influence+Survival+in+Alzheimer%E2%80%99s+Disease%3A+A+Population-Based+Longitudinal+Study&rft.jtitle=Neuroepidemiology&rft.au=Koivisto%2C+Anne+M.&rft.au=Lempi%C3%A4inen%2C+P%C3%A4ivi&rft.au=Koivisto%2C+Keijo&rft.au=Helkala%2C+Eeva-Liisa&rft.date=2000-11-01&rft.issn=0251-5350&rft.eissn=1423-0208&rft.volume=19&rft.issue=6&rft.spage=327&rft.epage=332&rft_id=info:doi/10.1159%2F000026272&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000026272 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0251-5350&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0251-5350&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0251-5350&client=summon |